Personal Care Products ASX Stock News and Announcements

18 November 2024

Investor Presentation November 2024

Bioxyne reports 119% revenue growth and strategic expansion in novel medicines.

Bioxyne Revenue Growth Stock Market News Cannabis Industry Psychedelic Medicines

Posted on: 18/11/2024

31 October 2024

Q1 F25 Activity Statement and Appendix 4C

Anagenics Limited outlines Q1 FY25 performance and ongoing restructuring for profitability.

Anagenics Limited Q1 FY25 Financial Performance Restructuring Stock Market News

Posted on: 31/10/2024

23 September 2024

Bioxyne Extends Contract with Aura Therapeutics

Bioxyne signs amendment to double THC flower product volumes and manufacture pastilles.

Bioxyne Aura Therapeutics Stock Market News Cannabis Industry Pharmaceutical Manufacturing

Posted on: 23/09/2024

17 September 2024

Reinstatement to Quotation

Bioxyne Limited resumes trading after clarification on cannabis gummies announcement.

Bioxyne Limited ASX Stock Market News Cannabis Gummies Pharmaceuticals

Posted on: 17/09/2024

Announcement 21.8.2024 Clarifying Statement

Bioxyne Limited provides additional details on its $28 million supply agreement.

Bioxyne Limited Medicinal Cannabis Supply Agreement Stock Market News Pharmaceuticals

Posted on: 17/09/2024

29 July 2024

Quarterly Activities/Appendix 4C Cash Flow Report

Elixinol Wellness sees 118% revenue growth in Q2 FY24.

Elixinol Wellness Q2 FY24 Revenue Growth Plant-Based Nutrition Stock Market News

Posted on: 29/07/2024